Edgestream Partners L.P. raised its stake in Xylem Inc. (NYSE:XYL – Free Report) by 118.3% in the first quarter, Holdings Channel reports. The fund owned 60,778 shares of the industrial products company’s stock after purchasing an additional 32,940 shares during the quarter. Edgestream Partners L.P.’s holdings in Xylem were worth $7,263,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in the stock. J. Stern & Co. LLP boosted its position in Xylem by 12,326.6% in the fourth quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock valued at $6,189,132,000 after buying an additional 45,082,435 shares in the last quarter. Norges Bank bought a new stake in shares of Xylem during the fourth quarter worth $361,012,000. SEB Asset Management AB acquired a new position in shares of Xylem during the first quarter worth $66,700,000. Balyasny Asset Management L.P. lifted its stake in shares of Xylem by 346.2% in the 3rd quarter. Balyasny Asset Management L.P. now owns 712,950 shares of the industrial products company’s stock valued at $105,160,000 after acquiring an additional 553,152 shares during the last quarter. Finally, Adage Capital Partners GP L.L.C. bought a new position in shares of Xylem in the 2nd quarter valued at $64,407,000. 87.96% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Xylem
In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of Xylem stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the transaction, the chief accounting officer owned 3,605 shares of the company’s stock, valued at $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jerome A. Peribere bought 1,210 shares of the company’s stock in a transaction that occurred on Monday, May 4th. The stock was purchased at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the acquisition, the director owned 27,209 shares of the company’s stock, valued at $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Corporate insiders own 0.32% of the company’s stock.
Xylem Trading Down 4.2%
Xylem (NYSE:XYL – Get Free Report) last announced its earnings results on Tuesday, July 28th. The industrial products company reported $1.46 EPS for the quarter, beating the consensus estimate of $1.34 by $0.12. The business had revenue of $2.34 billion for the quarter, compared to analysts’ expectations of $2.34 billion. Xylem had a return on equity of 11.77% and a net margin of 11.15%.The firm’s revenue was up 1.5% on a year-over-year basis. During the same period in the prior year, the business posted $1.26 earnings per share. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. On average, equities research analysts forecast that Xylem Inc. will post 5.64 earnings per share for the current year.
Xylem Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were given a dividend of $0.43 per share. The ex-dividend date was Thursday, May 28th. This represents a $1.72 annualized dividend and a dividend yield of 1.5%. Xylem’s dividend payout ratio is 42.79%.
Analyst Upgrades and Downgrades
A number of equities research analysts recently weighed in on the company. Robert W. Baird boosted their price objective on Xylem from $163.00 to $165.00 and gave the stock an “outperform” rating in a research report on Wednesday. Weiss Ratings lowered Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, May 8th. CLSA raised Xylem to a “hold” rating in a research note on Thursday, June 25th. Barclays raised their price objective on shares of Xylem from $154.00 to $159.00 and gave the company an “overweight” rating in a report on Wednesday. Finally, Citigroup reissued a “buy” rating on shares of Xylem in a report on Wednesday. Nine analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Xylem presently has a consensus rating of “Moderate Buy” and a consensus target price of $154.00.
Xylem Company Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Featured Stories
- Five stocks we like better than Xylem
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
